The Department of Ayush, which regulates the estimated Rs 6,000-crore ayurveda, siddha and unani Indian Systems of Medicine (ISM), has initiated new licensing norms to weed out irrational patent and proprietary (P&P) medicines, which are innovated products not mentioned in classical texts of the ISM.
The department’s move comes close on the heels of the Drug Controller General of India’s attempts to weed out ‘irrational’ pharmaceutical formulations or innovated fixed-dose combinations (FDCs) of known chemical compounds combined not in accordance with pharmacopoeia standards.
No comments:
Post a Comment